Real-time TaqMan RT-PCR Assays for Selective Detection of Human Rhinovirus


This invention relates to selective detection of human rhinovirus (HRV) in biological media. Specifically, this invention discloses a real-time TaqMan RT-PCR assay targeting the 5'-noncoding region of the HRV genome. This is a one-step, real-time nucleic acid assay that offers rapid, sensitive, and quantitative results. The assay is validated against all 100 recognized HRV prototype strains.

HRV is the most frequent cause of the common cold. From a clinical standpoint, diagnosis of HRV infection is quite difficult as the related symptoms can be caused by other agents as well. Additionally, laboratory detection of HRV is challenging as HRV exhibits extreme antigenic variability and certain strains cannot be maintained by cell culture.

Potential Commercial Applications: Competitive Advantages:
  • Development of human rhinovirus (HRV) diagnostics
  • Acute lower respiratory illness diagnostics and investigation
 
  • Validated against all 100 human rhinovirus prototype strains
  • Rapid, sensitive and quantitative
  • One-step assay
  • Easily adapted to kit form


Development Stage:
  • Early-stage
  • In vitro data available


  • Inventors:

    Xiaoyan Lu (CDC)  ➽ more inventions...

    Dean Erdman (CDC)  ➽ more inventions...


    Intellectual Property:
    U.S. Pat: 8,986,933 issued 2015-03-24
    US Application No. 14/570,569

    Publications:
    Lu X, et al. PMID 18057136

    Licensing Contact:
    Karen Surabian, J.D., M.B.A.
    Email: karen.surabian@nih.gov
    Phone: 301-594-9719

    OTT Reference No: E-177-2013/0
    Updated: Aug 13, 2013